Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal Tumor

Objective: Comparing scoring with RMI3 and RMI4 in establishing the diagnosis of adnexal tumour in RSUD Dr. Saiful Anwar Malang. Methods: Prospective cohort study with samples of all patients suspected of having an adnexal tumour diagnosed in gynecology policlinic using gynecological oncology policl...

Full description

Bibliographic Details
Main Authors: Tatit Nurseta, Yahya Irwanto, Nugrahanti Prasetyorini, Bambang Rahardjo, I Wayan Subage
Format: Article
Language:English
Published: Indonesian Society of Obstetrics and Gynecology 2020-10-01
Series:Indonesian Journal of Obstetrics and Gynecology
Online Access:http://inajog.com/index.php/journal/article/view/1342
id doaj-967237bfd1d64af18b22b3f3952a88bb
record_format Article
spelling doaj-967237bfd1d64af18b22b3f3952a88bb2021-06-02T16:21:16ZengIndonesian Society of Obstetrics and GynecologyIndonesian Journal of Obstetrics and Gynecology2338-64012338-73352020-10-0123724310.32771/inajog.v8i4.13421342Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal TumorTatit NursetaYahya IrwantoNugrahanti PrasetyoriniBambang RahardjoI Wayan SubageObjective: Comparing scoring with RMI3 and RMI4 in establishing the diagnosis of adnexal tumour in RSUD Dr. Saiful Anwar Malang. Methods: Prospective cohort study with samples of all patients suspected of having an adnexal tumour diagnosed in gynecology policlinic using gynecological oncology policlinic medical records at RSUD Dr. Saiful Anwar in the form of age, demographics, menopause status, Ca125, ultrasound results. Results: Between the RMI3 results and the results of histopathology, a contingency coeffi cient of 0.596 was obtained with a p-value of 0.000015 (p <0.05), with a PPV of 83%, an NPV of 91%. Between the RMI4 results and the histopathology results, a contingency coeffi cient of 0.657 with a p-value of 0.0000004 (p <0.05) was obtained, with a PPV of 92%, NPV of 95%. On the ROC curve, the area of the predicted results using the RMI4 score is higher than the RMI3 score. Conclusions: Using the RMI4 score results in more accurate predictions than the RMI3 score in detecting adnexal tumour malignancies. Keywords: adnexal tumours, diagnostic tests, ovarian tumours, risk of malignancy index, ultrasound.  Abstrak Tujuan: Membandingkan Skoring RMI3 dan RMI4 dalam menegakkan diagnosis tumor adneksa di RSUD dr. Saiful Anwar Malang. Metode: penelitian kohort prospective dengan sampel semua pasien yang dicurigai menderita tumor adneksa yang didiagnosis di poli Ginekologi menggunakan data rekam medis poli Ginekologi Onkologi RSUD dr. Saiful Anwar berupa usia, demografi , status menopause, Ca125, hasil USG. Hasil: Antara hasil RMI3 dengan hasil hispatologi, didapatkan koefi sien kontingensi sebesar 0,596 dengan p-value 0,000015 (p<0,05), dengan PPV 83%, NPV 91%. Antara hasil RMI4 dengan hasil histopatologi, didapatkan koefisien kontingensi sebesar 0,657 dengan p-value 0,0000004 (p<0,05), dengan PPV 92%, NPV 95%. Pada kurva ROC, luas area hasil prediksi dengan menggunakan skor RMI4 lebih tinggi daripada skor RMI3. Kesimpulan: Menggunakan skor RMI4 menghasilkan prediksi yang lebih tepat daripada skor RMI3 dalam mendeteksi keganasan tumor adneksa. Kata kunci: risk of malignancy index, tumor adneksa, tumor ovarium, uji diagnostik, USG.http://inajog.com/index.php/journal/article/view/1342
collection DOAJ
language English
format Article
sources DOAJ
author Tatit Nurseta
Yahya Irwanto
Nugrahanti Prasetyorini
Bambang Rahardjo
I Wayan Subage
spellingShingle Tatit Nurseta
Yahya Irwanto
Nugrahanti Prasetyorini
Bambang Rahardjo
I Wayan Subage
Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal Tumor
Indonesian Journal of Obstetrics and Gynecology
author_facet Tatit Nurseta
Yahya Irwanto
Nugrahanti Prasetyorini
Bambang Rahardjo
I Wayan Subage
author_sort Tatit Nurseta
title Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal Tumor
title_short Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal Tumor
title_full Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal Tumor
title_fullStr Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal Tumor
title_full_unstemmed Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal Tumor
title_sort risk of malignancy index 4 (rmi4) and risk of malignancy index 3 (rmi3) as diagnostic tests for adnexal tumor
publisher Indonesian Society of Obstetrics and Gynecology
series Indonesian Journal of Obstetrics and Gynecology
issn 2338-6401
2338-7335
publishDate 2020-10-01
description Objective: Comparing scoring with RMI3 and RMI4 in establishing the diagnosis of adnexal tumour in RSUD Dr. Saiful Anwar Malang. Methods: Prospective cohort study with samples of all patients suspected of having an adnexal tumour diagnosed in gynecology policlinic using gynecological oncology policlinic medical records at RSUD Dr. Saiful Anwar in the form of age, demographics, menopause status, Ca125, ultrasound results. Results: Between the RMI3 results and the results of histopathology, a contingency coeffi cient of 0.596 was obtained with a p-value of 0.000015 (p <0.05), with a PPV of 83%, an NPV of 91%. Between the RMI4 results and the histopathology results, a contingency coeffi cient of 0.657 with a p-value of 0.0000004 (p <0.05) was obtained, with a PPV of 92%, NPV of 95%. On the ROC curve, the area of the predicted results using the RMI4 score is higher than the RMI3 score. Conclusions: Using the RMI4 score results in more accurate predictions than the RMI3 score in detecting adnexal tumour malignancies. Keywords: adnexal tumours, diagnostic tests, ovarian tumours, risk of malignancy index, ultrasound.  Abstrak Tujuan: Membandingkan Skoring RMI3 dan RMI4 dalam menegakkan diagnosis tumor adneksa di RSUD dr. Saiful Anwar Malang. Metode: penelitian kohort prospective dengan sampel semua pasien yang dicurigai menderita tumor adneksa yang didiagnosis di poli Ginekologi menggunakan data rekam medis poli Ginekologi Onkologi RSUD dr. Saiful Anwar berupa usia, demografi , status menopause, Ca125, hasil USG. Hasil: Antara hasil RMI3 dengan hasil hispatologi, didapatkan koefi sien kontingensi sebesar 0,596 dengan p-value 0,000015 (p<0,05), dengan PPV 83%, NPV 91%. Antara hasil RMI4 dengan hasil histopatologi, didapatkan koefisien kontingensi sebesar 0,657 dengan p-value 0,0000004 (p<0,05), dengan PPV 92%, NPV 95%. Pada kurva ROC, luas area hasil prediksi dengan menggunakan skor RMI4 lebih tinggi daripada skor RMI3. Kesimpulan: Menggunakan skor RMI4 menghasilkan prediksi yang lebih tepat daripada skor RMI3 dalam mendeteksi keganasan tumor adneksa. Kata kunci: risk of malignancy index, tumor adneksa, tumor ovarium, uji diagnostik, USG.
url http://inajog.com/index.php/journal/article/view/1342
work_keys_str_mv AT tatitnurseta riskofmalignancyindex4rmi4andriskofmalignancyindex3rmi3asdiagnostictestsforadnexaltumor
AT yahyairwanto riskofmalignancyindex4rmi4andriskofmalignancyindex3rmi3asdiagnostictestsforadnexaltumor
AT nugrahantiprasetyorini riskofmalignancyindex4rmi4andriskofmalignancyindex3rmi3asdiagnostictestsforadnexaltumor
AT bambangrahardjo riskofmalignancyindex4rmi4andriskofmalignancyindex3rmi3asdiagnostictestsforadnexaltumor
AT iwayansubage riskofmalignancyindex4rmi4andriskofmalignancyindex3rmi3asdiagnostictestsforadnexaltumor
_version_ 1721402893732413440